{"id":"https://openalex.org/W2047501424","doi":"https://doi.org/10.1016/0009-9236(95)90162-0","title":"Alprazolam absorption kinetics affects abuse liability*","display_name":"Alprazolam absorption kinetics affects abuse liability*","alternate_titles":[],"publication_year":1995,"publication_date":"1995-03-01","ids":{"openalex":"https://openalex.org/W2047501424","doi":"https://doi.org/10.1016/0009-9236(95)90162-0","mag":"2047501424","pmid":"https://pubmed.ncbi.nlm.nih.gov/7697954"},"language":"en","primary_location":{"id":"doi:10.1016/0009-9236(95)90162-0","doi":"https://doi.org/10.1016/0009-9236(95)90162-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0009-9236(95)90162-0","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2047501424"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030558375","display_name":"Geoffrey K. Mumford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Geoffrey K. Mumford","raw_affiliation_strings":["Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Md., USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Md., USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Suzette M. Evans","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Suzette M. Evans","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113636240","display_name":"Joseph C. Fleishaker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joseph C. Fleishaker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5108109478","display_name":"Roland R. Griffiths","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roland R. Griffiths","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":2.3704,"has_fulltext":false,"cited_by_count":70,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.86471728,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"57","issue":"3","first_page":"356","last_page":"365"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.43309998512268066,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.43309998512268066,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.22200000286102295,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.15880000591278076,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alprazolam","display_name":"alprazolam","score":1.0},{"id":"https://openalex.org/keywords/extended-release-formulation","display_name":"sustained-release formulation","score":0.8679999709129333},{"id":"https://openalex.org/keywords/immediate-release-formulation","display_name":"immediate-release formulation","score":0.968999981880188},{"id":"https://openalex.org/keywords/drug-release-rate","display_name":"drug release rate","score":0.6460000276565552},{"id":"https://openalex.org/keywords/abuse-potential","display_name":"abuse liability","score":0.9359999895095825},{"id":"https://openalex.org/keywords/sedative-abuse","display_name":"sedative abuse","score":0.6990000009536743},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.5960000157356262},{"id":"https://openalex.org/keywords/psychomotor-function","display_name":"psychomotor performance","score":0.7459999918937683},{"id":"https://openalex.org/keywords/cognitive-performance","display_name":"cognitive performance","score":0.8550000190734863},{"id":"https://openalex.org/keywords/subjective-drug-effects","display_name":"subjective drug effects","score":0.8399999737739563},{"id":"https://openalex.org/keywords/drug-reinforcement","display_name":"drug reinforcement","score":0.4309999942779541}],"concepts":[{"id":"https://openalex.org/C2777196872","wikidata":"https://www.wikidata.org/wiki/Q319877","display_name":"Alprazolam","level":3,"score":0.9972935914993286},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.7004237174987793},{"id":"https://openalex.org/C2777965283","wikidata":"https://www.wikidata.org/wiki/Q5275755","display_name":"Digit symbol substitution test","level":4,"score":0.6580068469047546},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6575016975402832},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4934617578983307},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4773699939250946},{"id":"https://openalex.org/C3017944768","wikidata":"https://www.wikidata.org/wiki/Q1450463","display_name":"Poison control","level":2,"score":0.4412817358970642},{"id":"https://openalex.org/C3018251022","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Abuse liability","level":3,"score":0.426954984664917},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40338003635406494},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3927384316921234},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.28985947370529175},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.20433923602104187},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.2022598683834076},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.08704954385757446},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000525","descriptor_name":"Alprazolam","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000525","descriptor_name":"Alprazolam","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011597","descriptor_name":"Psychomotor Performance","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/0009-9236(95)90162-0","doi":"https://doi.org/10.1016/0009-9236(95)90162-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0009-9236(95)90162-0","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:7697954","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7697954","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G1829165996","display_name":"Clinical Pharmacology/Mechanisms of Action of Emerging Abused Drugs (Club Drugs)","funder_award_id":"R01DA003889","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W42752256","https://openalex.org/W54728729","https://openalex.org/W80826635","https://openalex.org/W1914827599","https://openalex.org/W1915339567","https://openalex.org/W1950497346","https://openalex.org/W1975904102","https://openalex.org/W1984291639","https://openalex.org/W1984739390","https://openalex.org/W2008032124","https://openalex.org/W2011181517","https://openalex.org/W2045676655","https://openalex.org/W2053648355","https://openalex.org/W2059831203","https://openalex.org/W2060873866","https://openalex.org/W2079055954","https://openalex.org/W2085038977","https://openalex.org/W2087546370","https://openalex.org/W2148624345","https://openalex.org/W2158902227","https://openalex.org/W2223213976","https://openalex.org/W2346692675","https://openalex.org/W2398404082","https://openalex.org/W2438616981","https://openalex.org/W4317639036","https://openalex.org/W4321060616","https://openalex.org/W4322694688"],"related_works":["https://openalex.org/W42752256","https://openalex.org/W2171722958","https://openalex.org/W2040254139","https://openalex.org/W2004107116","https://openalex.org/W1895388428","https://openalex.org/W1996492012","https://openalex.org/W2147899871","https://openalex.org/W2111331063","https://openalex.org/W2033124652","https://openalex.org/W1917052505"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"the":[3,19,198,217,229,242],"behavioral,":[4],"subjective,":[5],"and":[6,13,52,57,59,71,81,89,103,109,125,136,138,142,155,194],"reinforcing":[7,219],"effects":[8,175,220],"of":[9,21,27,36,123,152,172,178,184,197,221,233,252,259],"immediate-release":[10,55,107,118,253,275],"(IR)":[11],"alprazolam":[12,16,63,72,98,108,119,147,159,193,254,268],"extended-release":[14,62,110,146,158,192,206,260,267],"(XR)":[15],"to":[17,114,215,238,240],"assess":[18,216],"effect":[20],"release":[22],"rate":[23],"on":[24],"laboratory":[25],"measures":[26,122,154,171,186,200],"abuse":[28,38,273],"liability.":[29],"METHODS:":[30],"Fourteen":[31],"healthy":[32],"men":[33],"with":[34],"histories":[35],"sedative":[37],"participated":[39],"as":[40],"subjects":[41,48,235],"in":[42,64],"a":[43],"double-blind":[44],"crossover":[45],"study.":[46],"All":[47],"received":[49],"placebo,":[50,115],"1":[51],"2":[53,58,116,144,166,190],"mg":[54,61,117,145,157,191,205],"alprazolam,":[56,111,165],"3":[60,156,204],"random":[65],"order.":[66],"Behavioral":[67],"performance,":[68],"subjective":[69],"effects,":[70],"plasma":[73,99],"concentrations":[74,100],"were":[75,187,201,236],"assessed":[76],"repeatedly":[77],"1/2":[78],"hour":[79,227],"before":[80],"1/2,":[82],"1,":[83],"3,":[84],"5,":[85],"7,":[86],"9,":[87],"12,":[88],"24":[90,226],"hours":[91,105],"after":[92,106,228],"drug":[93,174,209,243],"administration.":[94],"RESULTS:":[95],"Mean":[96],"peak":[97],"occurred":[101],"1.7":[102],"9.2":[104],"respectively.":[112],"Compared":[113],"impaired":[120,160],"all":[121,169],"psychomotor":[124],"cognitive":[126],"performance":[127],"(Digit":[128],"Symbol":[129],"Substitution":[130],"Test),":[131],"motor":[132],"coordination":[133],"(circular":[134],"lights":[135,162],"balance),":[137],"memory":[139],"(digit":[140],"entry":[141],"recall);":[143],"did":[148],"not":[149],"affect":[150],"any":[151],"these":[153,185],"circular":[161],"only.":[163],"Immediate-release":[164],"mg,":[167],"increased":[168,188,202],"six":[170,199],"positive":[173],"(e.g.,":[176],"ratings":[177],"liking":[179],"or":[180],"good":[181],"effects);":[182],"none":[183],"by":[189,203],"only":[195],"three":[196],"alprazolam.":[207,261,276],"A":[208],"versus":[210],"money":[211,234],"multiple-choice":[212],"procedure":[213],"designed":[214],"relative":[218],"each":[222],"condition":[223],"was":[224,244],"administered":[225],"drug.":[230],"The":[231],"amount":[232],"willing":[237],"\"pay\"":[239],"take":[241],"significantly":[245],"greater":[246],"than":[247,274],"placebo":[248],"for":[249,256,272],"both":[250],"doses":[251],"but":[255],"neither":[257],"dose":[258],"CONCLUSIONS:":[262],"These":[263],"data":[264],"indicate":[265],"that":[266],"has":[269],"less":[270],"potential":[271]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2047501424","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
